References

Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains

10.1001/jamaneurol.2016.4370 · ExternalCitation · doi-reference

Astrocytic induction of triglyceride lipolysis in AD-associated pathology and neuroinflammation

10.1002/alz.093056 · ExternalCitation · doi-reference

Differences between blood and cerebrospinal fluid glial fibrillary acidic protein levels: the effect of sample stability

10.1002/alz.12806 · ExternalCitation · doi-reference

Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer’s disease progression

10.1002/alz.13450 · ExternalCitation · doi-reference

Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer’s disease patients

10.1002/alz.14125 · ExternalCitation · doi-reference

Synapse loss in frontal cortex biopsies in Alzheimer’s disease: correlation with cognitive severity

10.1002/ana.410270502 · ExternalCitation · doi-reference

The complex morphology of reactive astrocytes controlled by fibroblast growth factor signaling: reactive astrocyte morphology involves FGF

10.1002/glia.22684 · ExternalCitation · doi-reference

Region-specific reduction of Aβ-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging

10.1002/jnr.10390 · ExternalCitation · doi-reference

Expression of non-adrenergic imidazoline sites in rat cerebral cortical astrocytes

10.1002/jnr.490340611 · ExternalCitation · doi-reference

Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells: differential effects of calcineurin inhibitors

10.1002/lt.21358 · ExternalCitation · doi-reference

Vimentin immunoreactivity in normal and pathological human brain tissue

10.1007/bf00311389 · ExternalCitation · doi-reference

Early involvement of D-serine in β-amyloid-dependent pathophysiology

10.1007/s00018-025-05691-z · ExternalCitation · doi-reference

Astrocytes: biology and pathology

10.1007/s00401-009-0619-8 · ExternalCitation · doi-reference

Functional morphology of the blood–brain barrier in health and disease

10.1007/s00401-018-1815-1 · ExternalCitation · doi-reference

Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline

10.1007/s00401-020-02195-x · ExternalCitation · doi-reference

Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology

10.1007/s00401-021-02275-6 · ExternalCitation · doi-reference

Astroglial responses to amyloid-beta progression in a mouse model of Alzheimer’s disease

10.1007/s11307-017-1153-z · ExternalCitation · doi-reference

Loss of direct vascular contact to astrocytes in the hippocampus as an initial event in Alzheimer’s disease. evidence from patients, in vivo and in vitro experimental models

10.1007/s12035-023-03897-5 · ExternalCitation · doi-reference

An acidic protein isolated from fibrous astrocytes

10.1016/0006-8993(71)90668-8 · ExternalCitation · doi-reference

Astrocyte S100β expression and selective differentiation to GFAP and GS in the entorhinal cortex during ageing in the 3xTg-Alzheimer’s disease mouse model

10.1016/j.acthis.2023.152131 · ExternalCitation · doi-reference

The current agonists and positive allosteric modulators of α 7 nAChR for CNS indications in clinical trials

10.1016/j.apsb.2017.09.001 · ExternalCitation · doi-reference

Characterization of STAT3-expressing cells in the postnatal rat brain

10.1016/j.brainres.2006.04.115 · ExternalCitation · doi-reference

Aβ oligomers promote lipid droplet accumulation and inflammatory responses in astrocytes but not neurons

10.1016/j.brainresbull.2025.111556 · ExternalCitation · doi-reference

Astrocyte-neuron lactate transport is required for long-term memory formation

10.1016/j.cell.2011.02.018 · ExternalCitation · doi-reference

Neuron-astrocyte metabolic coupling protects against activity-induced fatty acid toxicity

10.1016/j.cell.2019.04.001 · ExternalCitation · doi-reference

Cholesterol and matrisome pathways dysregulated in astrocytes and microglia

10.1016/j.cell.2022.05.017 · ExternalCitation · doi-reference

Microglia-astrocyte crosstalk regulates synapse remodeling via Wnt signaling

10.1016/j.cell.2025.08.023 · ExternalCitation · doi-reference

Astrocytes functionally integrate multiple synapses via specialized leaflet domains

10.1016/j.cell.2025.08.036 · ExternalCitation · doi-reference

Multiscale proteomic modeling reveals protein networks driving Alzheimer’s disease pathogenesis

10.1016/j.cell.2025.08.038 · ExternalCitation · doi-reference

BACE1 regulates hippocampal astrogenesis via the Jagged1-Notch pathway

10.1016/j.celrep.2013.06.005 · ExternalCitation · doi-reference

Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy

10.1016/j.celrep.2019.07.060 · ExternalCitation · doi-reference

ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism

10.1016/j.celrep.2020.108572 · ExternalCitation · doi-reference

Astrocyte calcium dysfunction causes early network hyperactivity in Alzheimer’s disease

10.1016/j.celrep.2022.111280 · ExternalCitation · doi-reference

ApoE4-dependent lysosomal cholesterol accumulation impairs mitochondrial homeostasis and oxidative phosphorylation in human astrocytes

10.1016/j.celrep.2023.113183 · ExternalCitation · doi-reference

Fate-mapping of GM-CSF expression identifies a discrete subset of inflammation-driving T helper cells regulated by cytokines IL-23 and IL-1β

10.1016/j.immuni.2019.04.006 · ExternalCitation · doi-reference

The accumulation of tau-immunoreactive hippocampal granules and corpora amylacea implicates reactive glia in tau pathogenesis during aging

10.1016/j.isci.2020.101255 · ExternalCitation · doi-reference

The role of astrocytes in CNS inflammation

10.1016/j.it.2020.07.007 · ExternalCitation · doi-reference

Inhibition of STAT3 phosphorylation attenuates impairments in learning and memory in 5XFAD mice, an animal model of Alzheimer’s disease

10.1016/j.jphs.2020.05.009 · ExternalCitation · doi-reference

Complex roles for reactive astrocytes in the triple transgenic mouse model of Alzheimer disease

10.1016/j.neurobiolaging.2020.02.010 · ExternalCitation · doi-reference

Adenosine A2A receptors are essential for long-term potentiation of NMDA-EPSCs at hippocampal mossy fiber synapses

10.1016/j.neuron.2007.11.023 · ExternalCitation · doi-reference

Propagation of tau pathology in a model of early Alzheimer’s disease

10.1016/j.neuron.2011.11.033 · ExternalCitation · doi-reference

NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer’s disease

10.1016/j.neuron.2014.11.018 · ExternalCitation · doi-reference

GLUT4 mobilization supports energetic demands of active synapses

10.1016/j.neuron.2016.12.020 · ExternalCitation · doi-reference

Septal cholinergic neuromodulation tunes the astrocyte-dependent gating of hippocampal NMDA receptors to wakefulness

10.1016/j.neuron.2017.04.021 · ExternalCitation · doi-reference

Astroglial CB1 receptors determine synaptic D-serine availability to enable recognition memory

10.1016/j.neuron.2018.04.034 · ExternalCitation · doi-reference

APOE4 causes widespread molecular and cellular alterations associated with Alzheimer’s disease phenotypes in human iPSC-derived brain cell types

10.1016/j.neuron.2018.06.011 · ExternalCitation · doi-reference

Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer’s disease

10.1016/j.neuron.2018.10.031 · ExternalCitation · doi-reference

Apolipoprotein E: structural insights and links to Alzheimer disease pathogenesis

10.1016/j.neuron.2020.10.008 · ExternalCitation · doi-reference

Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia

10.1016/j.neuron.2021.03.024 · ExternalCitation · doi-reference

An astrocyte BMAL1-BAG3 axis protects against alpha-synuclein and tau pathology

10.1016/j.neuron.2023.05.006 · ExternalCitation · doi-reference

Irisin reduces amyloid-β by inducing the release of neprilysin from astrocytes following downregulation of ERK-STAT3 signaling

10.1016/j.neuron.2023.08.012 · ExternalCitation · doi-reference

Astrocyte-secreted neurocan controls inhibitory synapse formation and function

10.1016/j.neuron.2024.03.007 · ExternalCitation · doi-reference

Selective removal of astrocytic PERK protects against glymphatic impairment and decreases toxic aggregation of β-amyloid and tau

10.1016/j.neuron.2025.04.027 · ExternalCitation · doi-reference

Astrocyte-microglia crosstalk through Hevin and Toll-like receptor signaling controls developmental thalamocortical synapse refinement

10.1016/j.neuron.2025.12.028 · ExternalCitation · doi-reference

Astrocyte EV-induced lincRNA-Cox2 regulates microglial phagocytosis: implications for morphine-mediated neurodegeneration

10.1016/j.omtn.2018.09.019 · ExternalCitation · doi-reference

Calcineurin inhibitors improve memory loss and neuropathological changes in mouse model of dementia

10.1016/j.pbb.2016.12.018 · ExternalCitation · doi-reference

The role of sphingosine 1-phosphate metabolism in brain health and disease

10.1016/j.pharmthera.2023.108381 · ExternalCitation · doi-reference

Astrocytic EphB3 receptors regulate d-serine-gated synaptic plasticity and memory

10.1016/j.pneurobio.2025.102747 · ExternalCitation · doi-reference

APOE4-carrying human astrocytes oversupply cholesterol to promote neuronal lipid raft expansion and Aβ generation

10.1016/j.stemcr.2021.07.017 · ExternalCitation · doi-reference

Induction of astrocyte reactivity promotes neurodegeneration in human pluripotent stem cell models

10.1016/j.stemcr.2024.07.002 · ExternalCitation · doi-reference

Greasing the synaptic vesicle cycle by membrane lipids

10.1016/j.tcb.2013.05.002 · ExternalCitation · doi-reference

Astrocytes and microglia: in sickness and in health

10.1016/j.tins.2020.01.003 · ExternalCitation · doi-reference

α7 nicotinic acetylcholine receptors in the hippocampal circuit: taming complexity

10.1016/j.tins.2021.11.006 · ExternalCitation · doi-reference

Tripartite synapses: glia, the unacknowledged partner

10.1016/s0166-2236(98)01349-6 · ExternalCitation · doi-reference

Aging-related down-regulation of neprilysin, a putative β-amyloid-degrading enzyme, in transgenic Tg2576 Alzheimer-like mouse brain is accompanied by an astroglial upregulation in the vicinity of β-amyloid plaques

10.1016/s0304-3940(03)00030-2 · ExternalCitation · doi-reference

Blood phosphorylated tau 181 as a biomarker for Alzheimer’s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts

10.1016/s1474-4422(20)30071-5 · ExternalCitation · doi-reference

CXCR4-activated astrocyte glutamate release via TNFα: amplification by microglia triggers neurotoxicity

10.1038/89490 · ExternalCitation · doi-reference

Neurotoxic reactive astrocytes are induced by activated microglia

10.1038/nature21029 · ExternalCitation · doi-reference

ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

10.1038/nature24016 · ExternalCitation · doi-reference

Metabotropic P2Y1 receptor signalling mediates astrocytic hyperactivity in vivo in an Alzheimer’s disease mouse model

10.1038/ncomms6422 · ExternalCitation · doi-reference

GABA from reactive astrocytes impairs memory in mouse models of Alzheimer’s disease

10.1038/nm.3639 · ExternalCitation · doi-reference

Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation

10.1038/nm.3681 · ExternalCitation · doi-reference

Astrocyte calcium signaling: the third wave

10.1038/nn.4201 · ExternalCitation · doi-reference

Fibroblast growth factor signalling: from development to cancer

10.1038/nrc2780 · ExternalCitation · doi-reference

Lactate in the brain: from metabolic end-product to signalling molecule

10.1038/nrn.2018.19 · ExternalCitation · doi-reference

The molecular basis of water transport in the brain

10.1038/nrn1252 · ExternalCitation · doi-reference

NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease

10.1038/nrn3504 · ExternalCitation · doi-reference

Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load

10.1038/s41380-021-01193-z · ExternalCitation · doi-reference

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

10.1038/s41380-021-01429-y · ExternalCitation · doi-reference

Increasing hexokinase 1 expression improves mitochondrial and glycolytic functional deficits seen in sporadic Alzheimer’s disease astrocytes

10.1038/s41380-024-02746-8 · ExternalCitation · doi-reference

Upregulation of adenosine A2A receptor in astrocytes is sufficient to trigger hippocampal multicellular dysfunctions and memory deficits

10.1038/s41380-025-03115-9 · ExternalCitation · doi-reference

APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

10.1038/s41467-020-19264-0 · ExternalCitation · doi-reference

Filamentous recombinant human Tau activates primary astrocytes via an integrin receptor complex

10.1038/s41467-020-20322-w · ExternalCitation · doi-reference

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

10.1038/s41467-021-27702-w · ExternalCitation · doi-reference

Reactive astrocytes transduce inflammation in a blood-brain barrier model through a TNF-STAT3 signaling axis and secretion of alpha 1-antichymotrypsin

10.1038/s41467-022-34412-4 · ExternalCitation · doi-reference

Rescue of astrocyte activity by the calcium sensor STIM1 restores long-term synaptic plasticity in female mice modelling Alzheimer’s disease

10.1038/s41467-023-37240-2 · ExternalCitation · doi-reference

Astrocytic GLUT1 deletion in adult mice enhances glucose metabolism and resilience to stroke

10.1038/s41467-025-59400-2 · ExternalCitation · doi-reference

Astrocyte priming enhances microglial Aβ clearance and is compromised by APOE4

10.1038/s41467-025-62995-1 · ExternalCitation · doi-reference

Plasma p-tau217 as a biomarker of Alzheimer’s disease pathology in individuals with Down syndrome

10.1038/s41467-025-65882-x · ExternalCitation · doi-reference

Motor learning and dopamine-dependent striatal synaptic plasticity are controlled by astrocytic MEGF10

10.1038/s41467-026-69129-1 · ExternalCitation · doi-reference

Cellular mechanisms of brain lipid metabolism in health and disease

10.1038/s41556-026-01880-5 · ExternalCitation · doi-reference

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

10.1038/s41573-020-0072-x · ExternalCitation · doi-reference

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

10.1038/s41582-019-0228-7 · ExternalCitation · doi-reference

Knowing the enemy: strategic targeting of complement to treat Alzheimer disease

10.1038/s41582-025-01073-y · ExternalCitation · doi-reference

Astrocytes phagocytose adult hippocampal synapses for circuit homeostasis

10.1038/s41586-020-03060-3 · ExternalCitation · doi-reference

MAFG-driven astrocytes promote CNS inflammation

10.1038/s41586-020-1999-0 · ExternalCitation · doi-reference

APOE4 leads to blood–brain barrier dysfunction predicting cognitive decline

10.1038/s41586-020-2247-3 · ExternalCitation · doi-reference

Specialized astrocytes mediate glutamatergic gliotransmission in the CNS

10.1038/s41586-023-06502-w · ExternalCitation · doi-reference

Adenosine signalling to astrocytes coordinates brain metabolism and function

10.1038/s41586-024-07611-w · ExternalCitation · doi-reference

Molecular mechanism of ligand gating and opening of NMDA receptor

10.1038/s41586-024-07742-0 · ExternalCitation · doi-reference

Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction

10.1038/s41591-018-0297-y · ExternalCitation · doi-reference

Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease

10.1038/s41591-019-0695-9 · ExternalCitation · doi-reference

Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation

10.1038/s41591-020-0815-6 · ExternalCitation · doi-reference

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease

10.1038/s41591-023-02380-x · ExternalCitation · doi-reference

Tau accumulation in astrocytes of the dentate gyrus induces neuronal dysfunction and memory deficits in Alzheimer’s disease

10.1038/s41593-020-00728-x · ExternalCitation · doi-reference

Severe reactive astrocytes precipitate pathological hallmarks of Alzheimer’s disease via H2O2− production

10.1038/s41593-020-00735-y · ExternalCitation · doi-reference

Reactive astrocyte nomenclature, definitions, and future directions

10.1038/s41593-020-00783-4 · ExternalCitation · doi-reference

Disease-associated astrocytes in Alzheimer’s disease and aging

10.1038/s41593-020-0624-8 · ExternalCitation · doi-reference

Fear learning induces α7-nicotinic acetylcholine receptor-mediated astrocytic responsiveness that is required for memory persistence

10.1038/s41593-021-00949-8 · ExternalCitation · doi-reference

Apolipoprotein E in Alzheimer’s disease trajectories and the next-generation clinical care pathway

10.1038/s41593-024-01669-5 · ExternalCitation · doi-reference

Astrocyte transcriptomic changes along the spatiotemporal progression of Alzheimer’s disease

10.1038/s41593-024-01791-4 · ExternalCitation · doi-reference

A glial circadian gene expression atlas reveals cell-type and disease-specific reprogramming in response to amyloid pathology or aging

10.1038/s41593-025-02067-1 · ExternalCitation · doi-reference

Astrocytic Ca2+ prevents synaptic depotentiation by limiting repetitive activity in dendrites during motor learning

10.1038/s41593-025-02072-4 · ExternalCitation · doi-reference

Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease

10.1038/s41593-025-02103-0 · ExternalCitation · doi-reference

Activated forms of astrocytes with higher GLT-1 expression are associated with cognitive normal subjects with Alzheimer pathology in human brain

10.1038/s41598-018-19442-7 · ExternalCitation · doi-reference

Sonic hedgehog signaling is negatively regulated in reactive astrocytes after forebrain stab injury

10.1038/s41598-018-37555-x · ExternalCitation · doi-reference

Exploring fatty acid metabolism in Alzheimer’s disease: the key role of CPT1A

10.1038/s41598-024-82999-z · ExternalCitation · doi-reference

Astrocytes enhance plasticity response during reversal learning

10.1038/s42003-024-06540-8 · ExternalCitation · doi-reference

Cell-specific expression of key mitochondrial enzymes limits OXPHOS in astrocytes of the adult human neocortex and hippocampal formation

10.1038/s42003-024-06751-z · ExternalCitation · doi-reference

Loss of fatty acid degradation by astrocytic mitochondria triggers neuroinflammation and neurodegeneration

10.1038/s42255-023-00756-4 · ExternalCitation · doi-reference

Fatty acid oxidation organizes mitochondrial supercomplexes to sustain astrocytic ROS and cognition

10.1038/s42255-023-00835-6 · ExternalCitation · doi-reference

Complement C1q-dependent excitatory and inhibitory synapse elimination by astrocytes and microglia in Alzheimer’s disease mouse models

10.1038/s43587-022-00281-1 · ExternalCitation · doi-reference

APOE from astrocytes restores Alzheimer’s Aβ-pathology and DAM-like responses in APOE deficient microglia

10.1038/s44321-024-00162-7 · ExternalCitation · doi-reference

Up-regulation of neprilysin mediates the protection of fructo-oligosaccharides against Alzheimer’s disease

10.1039/d0fo00161a · ExternalCitation · doi-reference

10.1056/nejmc2301380

10.1056/nejmc2301380 · ExternalCitation · doi-reference

Glial protein S100B modulates long-term neuronal synaptic plasticity

10.1073/pnas.052020999 · ExternalCitation · doi-reference

FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation

10.1073/pnas.1014154108 · ExternalCitation · doi-reference

Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss

10.1073/pnas.1306832110 · ExternalCitation · doi-reference

Astrocyte activation is suppressed in both normal and injured brain by FGF signaling

10.1073/pnas.1320401111 · ExternalCitation · doi-reference

The NMDA receptor activation by d-serine and glycine is controlled by an astrocytic Phgdh-dependent serine shuttle

10.1073/pnas.1909458116 · ExternalCitation · doi-reference

Astrocyte-secreted glypican-4 drives APOE4-dependent tau hyperphosphorylation

10.1073/pnas.2108870119 · ExternalCitation · doi-reference

Circadian clock protein BMAL1 broadly influences autophagy and endolysosomal function in astrocytes

10.1073/pnas.2220551120 · ExternalCitation · doi-reference

Astrocyte-targeting therapy rescues cognitive impairment caused by neuroinflammation via the Nrf2 pathway

10.1073/pnas.2303809120 · ExternalCitation · doi-reference

β-Amyloid1–42 binds to α7 nicotinic acetylcholine receptor with high affinity

10.1074/jbc.275.8.5626 · ExternalCitation · doi-reference

Amyloid-β regulates gap junction protein connexin 43 trafficking in cultured primary astrocytes

10.1074/jbc.ra120.013705 · ExternalCitation · doi-reference

Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease

10.1080/15548627.2016.1159375 · ExternalCitation · doi-reference

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease

10.1084/jem.20140413 · ExternalCitation · doi-reference

APOE4 derived from astrocytes leads to blood–brain barrier impairment

10.1093/brain/awab478 · ExternalCitation · doi-reference

Aqp4 stop codon readthrough facilitates amyloid-β clearance from the brain

10.1093/brain/awac199 · ExternalCitation · doi-reference

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

10.1093/brain/awv404 · ExternalCitation · doi-reference

Astrocyte regulation of synapse formation, maturation, and elimination

10.1101/cshperspect.a041352 · ExternalCitation · doi-reference

Alpha-smooth muscle actin (α-SMA) and nestin expression in reactive astrocytes in multiple sclerosis lesions: potential regulatory role of transforming growth factor-beta 1 (TGF-β1)

10.1111/j.1365-2990.2007.00910.x · ExternalCitation · doi-reference

Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer’s brain: Aβ-degrading enzymes profiling in Alzheimer’s brain

10.1111/j.1471-4159.2010.06899.x · ExternalCitation · doi-reference

ATP and glutamate released via astroglial connexin 43 hemichannels mediate neuronal death through activation of pannexin 1 hemichannels

10.1111/j.1471-4159.2011.07210.x · ExternalCitation · doi-reference

S100B induces tau protein hyperphosphorylation via Dickopff-1 up-regulation and disrupts the Wnt pathway in human neural stem cells

10.1111/j.1582-4934.2008.00159.x · ExternalCitation · doi-reference

Cross-talk between calcineurin/NFAT and Jak/STAT signalling induces cardioprotective αB-crystallin gene expression in response to hypertrophic stimuli

10.1111/j.1582-4934.2009.00804.x · ExternalCitation · doi-reference

Alzheimer’s Aβ42 and Aβ40 peptides form interlaced amyloid fibrils

10.1111/jnc.12202 · ExternalCitation · doi-reference

Sonic hedgehog signalling mediates astrocyte crosstalk with neurons to confer neuroprotection

10.1111/jnc.14064 · ExternalCitation · doi-reference

High-density lipoprotein mimetic peptide 4F mitigates amyloid-β-induced inhibition of apolipoprotein E secretion and lipidation in primary astrocytes and microglia

10.1111/jnc.14554 · ExternalCitation · doi-reference

A novel histone deacetylase inhibitor-based approach to eliminate microglia and retain astrocyte properties in glial cell culture

10.1111/jnc.15581 · ExternalCitation · doi-reference

Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer’s disease

10.1111/jnc.16014 · ExternalCitation · doi-reference

Altered metabolic function induced by Aβ-oligomers and PSEN1 mutations in iPSC-derived astrocytes

10.1111/jnc.16267 · ExternalCitation · doi-reference

Calcium-dependent signaling in astrocytes: downstream mechanisms and implications for cognition

10.1111/jnc.70019 · ExternalCitation · doi-reference

Clinical trials and late-stage drug development for Alzheimer’s disease: an appraisal from 1984 to 2014

10.1111/joim.12191 · ExternalCitation · doi-reference

Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition

10.1113/jphysiol.2014.278754 · ExternalCitation · doi-reference

Therapeutic targeting of α7 nicotinic acetylcholine receptors

10.1124/pharmrev.120.000097 · ExternalCitation · doi-reference

The neuronal S100B protein is a calcium-tuned suppressor of amyloid-β aggregation

10.1126/sciadv.aaq1702 · ExternalCitation · doi-reference

Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease

10.1126/sciadv.aav0316 · ExternalCitation · doi-reference

Disruption of BAG3-mediated BACE1 stabilization alleviates neuropathology and memory deficits in a mouse model of Alzheimer’s disease

10.1126/sciadv.adt7981 · ExternalCitation · doi-reference

The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence

10.1126/science.1206936 · ExternalCitation · doi-reference

Alzheimer’s disease: the amyloid cascade hypothesis

10.1126/science.1566067 · ExternalCitation · doi-reference

Restoring hippocampal glucose metabolism rescues cognition across Alzheimer’s disease pathologies

10.1126/science.abm6131 · ExternalCitation · doi-reference

Targeting amyloid-β pathology by chimeric antigen receptor astrocyte (CAR-A) therapy

10.1126/science.ads3972 · ExternalCitation · doi-reference

Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases

10.1126/scitranslmed.abe5640 · ExternalCitation · doi-reference

Astrocytic α2-Na/K ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model

10.1126/scitranslmed.abm4107 · ExternalCitation · doi-reference

Astrocyte endfeet in brain function and pathology: open questions

10.1146/annurev-neuro-091922-031205 · ExternalCitation · doi-reference

Transcription factors of the NFAT family: regulation and function

10.1146/annurev.immunol.15.1.707 · ExternalCitation · doi-reference

Aducanumab therapy to treat Alzheimer’s disease: a narrative review

10.1155/2022/9343514 · ExternalCitation · doi-reference

PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation

10.1186/1742-2094-7-78 · ExternalCitation · doi-reference

The contribution of activated astrocytes to Aβ production: implications for Alzheimer’s disease pathogenesis

10.1186/1742-2094-8-150 · ExternalCitation · doi-reference

BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer’s disease

10.1186/1750-1326-7-52 · ExternalCitation · doi-reference

Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes

10.1186/ar4162 · ExternalCitation · doi-reference

Inhibition of NF-κB in astrocytes is sufficient to delay neurodegeneration induced by proteotoxicity in neurons

10.1186/s12974-018-1278-2 · ExternalCitation · doi-reference

Transgenic inhibition of astroglial NF-κB restrains the neuroinflammatory and neurodegenerative outcomes of experimental mouse glaucoma

10.1186/s12974-020-01930-1 · ExternalCitation · doi-reference

C1q/TNF-related protein 4 restores leptin sensitivity by downregulating NF-κB signaling and microglial activation

10.1186/s12974-021-02167-2 · ExternalCitation · doi-reference

Amyloid-β accumulation in human astrocytes induces mitochondrial disruption and changed energy metabolism

10.1186/s12974-023-02722-z · ExternalCitation · doi-reference

Bridging regional neurovascular unit heterogeneity and cognitive function: a review

10.1186/s12987-025-00697-y · ExternalCitation · doi-reference

Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits

10.1186/s13024-015-0056-1 · ExternalCitation · doi-reference

APOE effects on regional tau in preclinical Alzheimer’s disease

10.1186/s13024-022-00590-4 · ExternalCitation · doi-reference

BACE1 regulates expression of clusterin in astrocytes for enhancing clearance of β-amyloid peptides

10.1186/s13024-023-00611-w · ExternalCitation · doi-reference

SIRT2 and ALDH1A1 as critical enzymes for astrocytic GABA production in Alzheimer’s disease

10.1186/s13024-024-00788-8 · ExternalCitation · doi-reference

Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis

10.1186/s13024-025-00796-2 · ExternalCitation · doi-reference

Disruption of the astrocyte–neuron interaction is responsible for the impairments in learning and memory in 5XFAD mice: an Alzheimer’s disease animal model

10.1186/s13041-021-00823-5 · ExternalCitation · doi-reference

Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment

10.1186/s13195-021-00804-9 · ExternalCitation · doi-reference

Loss of perivascular aquaporin-4 localization impairs glymphatic exchange and promotes amyloid β plaque formation in mice

10.1186/s13195-022-00999-5 · ExternalCitation · doi-reference

Plasma phospho-tau217 as a predictive biomarker for Alzheimer’s disease in a large south American cohort

10.1186/s13195-024-01655-w · ExternalCitation · doi-reference

Extracellular PHF-tau modulates astrocyte mitochondrial dynamics and mediates neuronal connectivity

10.1186/s40035-025-00474-9 · ExternalCitation · doi-reference

Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions

10.1186/s40478-017-0478-9 · ExternalCitation · doi-reference

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease

10.1186/s40478-018-0606-1 · ExternalCitation · doi-reference

Astrocytes respond to a neurotoxic Aβ fragment with state-dependent Ca2+ alteration and multiphasic transmitter release

10.1186/s40478-021-01146-1 · ExternalCitation · doi-reference

Astrocytic uptake of neuronal corpses promotes cell-to-cell spreading of tau pathology

10.1186/s40478-023-01589-8 · ExternalCitation · doi-reference

Astrocytic accumulation of tau fibrils isolated from Alzheimer’s disease brains induces inflammation, cell-to-cell propagation and neuronal impairment

10.1186/s40478-024-01745-8 · ExternalCitation · doi-reference

PS1/gamma-secretase acts as rogue chaperone of glutamate transporter EAAT2/GLT-1 in Alzheimer’s disease

10.1186/s40478-024-01876-y · ExternalCitation · doi-reference

Synemin is expressed in reactive astrocytes in neurotrauma and interacts differentially with vimentin and GFAP intermediate filament networks

10.1242/jcs.03423 · ExternalCitation · doi-reference

Aging-associated cognitive decline is reversed by D-serine supplementation

10.1523/eneuro.0176-22.2022 · ExternalCitation · doi-reference

Cell-mediated neuroprotection in a mouse model of human tauopathy

10.1523/jneurosci.0834-10.2010 · ExternalCitation · doi-reference

Calcineurin/NFAT signaling in activated astrocytes drives network hyperexcitability in Aβ-bearing mice

10.1523/jneurosci.0877-17.2017 · ExternalCitation · doi-reference

Glutamate mediates acute glucose transport inhibition in hippocampal neurons

10.1523/jneurosci.1882-04.2004 · ExternalCitation · doi-reference

Blockade of astrocytic calcineurin/NFAT signaling helps to normalize hippocampal synaptic function and plasticity in a rat model of traumatic brain injury

10.1523/jneurosci.1930-15.2016 · ExternalCitation · doi-reference

Neuronally derived soluble abeta evokes cell-wide astrocytic calcium dysregulation in absence of amyloid plaques in vivo

10.1523/jneurosci.1988-22.2023 · ExternalCitation · doi-reference

Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer’s disease

10.1523/jneurosci.2323-12.2012 · ExternalCitation · doi-reference

Astrocyte transforming growth factor beta 1 protects synapses against Aβ oligomers in Alzheimer’s disease model

10.1523/jneurosci.3351-16.2017 · ExternalCitation · doi-reference

The JAK/STAT3 pathway is a common inducer of astrocyte reactivity in Alzheimer’s and Huntington’s diseases

10.1523/jneurosci.3516-14.2015 · ExternalCitation · doi-reference

Amyloid β-induced death in neurons involves glial and neuronal hemichannels

10.1523/jneurosci.6417-10.2011 · ExternalCitation · doi-reference

Inhibition of Stat3-mediated astrogliosis ameliorates pathology in an Alzheimer’s disease model

10.15252/emmm.201809665 · ExternalCitation · doi-reference

S100A13 promotes senescence-associated secretory phenotype and cellular senescence via modulation of non-classical secretion of IL-1α

10.18632/aging.101760 · ExternalCitation · doi-reference

Aβ oligomers induce glutamate release from hippocampal neurons

10.2174/156720511796391917 · ExternalCitation · doi-reference

Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG

10.2967/jnumed.110.087031 · ExternalCitation · doi-reference

Evaluation of 11C-BU99008, a positron emission tomography ligand for the Imidazoline2 binding site in human brain

10.2967/jnumed.118.208009 · ExternalCitation · doi-reference

AQP4 association with amyloid deposition and astrocyte pathology in the Tg-ArcSwe mouse model of Alzheimer’s disease

10.3233/jad-160957 · ExternalCitation · doi-reference

Increased serum beta-secretase 1 activity is an early marker of Alzheimer’s disease

10.3233/jad-215542 · ExternalCitation · doi-reference

Siponimod (BAF312) activates Nrf2 while hampering NFκB in human astrocytes, and protects from astrocyte-induced neurodegeneration

10.3389/fimmu.2020.00635 · ExternalCitation · doi-reference

NF-κB and TNF affect the astrocytic differentiation from neural stem cells

10.3390/cells10040840 · ExternalCitation · doi-reference

IKK2/NF-κB activation in astrocytes reduces amyloid β deposition: a process associated with specific microglia polarization

10.3390/cells10102669 · ExternalCitation · doi-reference

Astrocyte and L-lactate in the anterior cingulate cortex modulate schema memory and neuronal mitochondrial biogenesis

10.7554/elife.85751 · ExternalCitation · doi-reference